Enzo Biochem Inc/ US2941001024 /
05/06/2024 22:10:00 | Chg. +0.01 | Volume | Bid05/06/2024 | Ask05/06/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1.16USD | +0.87% | 39,367 Turnover: 44,747.79 |
1.09Bid Size: 100 | 1.23Ask Size: 100 | 59.42 mill.USD | - | 2.83 |
Assets
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 7.6360 | 14.2540 | 14.4820 | 16.5850 | 17.2590 | ||||||
Intangible Assets | 1.8860 | 1.0320 | .5380 | .2440 | 0.0000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 18.4600 | 25.1870 | 43.7730 | 43.1090 | 41.5030 | ||||||
Inventories | 7.2780 | 7.8420 | 7.7840 | 12.6520 | 15.4110 | ||||||
Accounts Receivable | 13.1470 | 10.7380 | 9.1410 | 10.1980 | 11.5160 | ||||||
Cash and Cash Equivalents | 60.0410 | 60.1460 | 47.8650 | 13.5240 | 21.6030 | ||||||
Current Assets | 83.2000 | 81.4530 | 68.7650 | 70.5820 | 54.3540 | ||||||
Total Assets | 101.6600 | 106.6400 | 112.5380 | 113.6910 | 95.8570 |
Liabilities
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 9.5160 | 7.2560 | 8.5030 | 8.1230 | 8.5080 | ||||||
Long-term debt | - | 4.1790 | 4.4850 | 4.4710 | 4.0860 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 10.1000 | 8.4000 | 12.8000 | - | - | ||||||
Liabilities | 20.5390 | 20.6120 | 54.1570 | 45.1050 | 41.3950 | ||||||
Share Capital | .4720 | .4760 | .4790 | .4850 | .4870 | ||||||
Total Equity | 81.1210 | 86.0280 | 58.3810 | 68.5860 | 54.4620 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 101.6600 | 106.6400 | 112.5380 | 113.6910 | 95.8570 |
Income Statement
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 104.7130 | 81.1700 | 76.0210 | 117.7310 | 107.0710 | ||||||
Depreciation (total) | 3.1300 | 3.0360 | 2.7800 | 2.6530 | - | ||||||
Operating Result | -12.1640 | 1.7330 | -30.3670 | .6920 | -15.0070 | ||||||
Interest Income | .8530 | 1.0560 | .4540 | .0080 | .1590 | ||||||
Income Before Taxes | -11.4180 | 2.4890 | -28.5200 | 7.8750 | -18.2610 | ||||||
Income Taxes | -1.0970 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | -10.3210 | 2.4890 | -28.5200 | 7.8750 | -18.2610 |
Per Share
Cash Flow
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -2.7350 | 4.8060 | -17.1790 | .3870 | -16.5900 | ||||||
Cash Flow from Investing Activities | -1.9440 | -8.1260 | -2.1700 | -34.4970 | 25.2230 | ||||||
Cash Flow from Financing | .5590 | 4.1930 | 7.0010 | -.2420 | -.2410 | ||||||
Decrease / Increase in Cash | -4.1260 | .8550 | -12.2810 | -34.3410 | 8.3290 | ||||||
Employees | 460 | 500 | 448 | - | - |